An official website of the United States government. 
News Release 25-037
Inv. No(s). 337-TA-1444
Contact: Claire Huber, 202-205-1819
The U.S. International Trade Commission (Commission or USITC) voted to institute an investigation of certain nasal devices and components thereof. The products at issue in the investigation are described in the Commission’s notice of investigation.
The investigation is based on a complaint filed by Aardvark Medical Inc. of Denton, Tex., on February 18, 2025, and supplemented on February 25, 2025. The complaint, as supplemented, alleges violations of section 337 of the Tariff Act of 1930 in the importation into the United States and sale of certain nasal devices and components thereof that infringe patents asserted by the complainant. The complainant requests that the USITC issue a limited exclusion order and cease and desist orders.
The USITC has identified the following respondents in this investigation:
- Xiamenximier Electronic Commerce Co., Ltd. (d/b/a Cenny), Xiamen City, China
- Xia Men Deng Jia E-Commerce Co., Ltd. (d/b/a Ronfnea), Xiamen, China
- Chongqing Moffy Innovation Technology Co., Ltd., Chongqing City, China
- Guangdong XINRUNTAO Technology Co., Ltd., Guangdong, China
- Shenzhen Jun&Liang Media Tech Limited, Shenzhen, China
- RhinoSystems, Inc., Brooklyn, Ohio
- Spa Sciences LP, Port St. Lucie, Fl.
By instituting this investigation (337-TA-1444), the USITC has not yet made any decision on the merits of the case. The USITC’s Chief Administrative Law Judge will assign the case to one of the USITC’s administrative law judges (ALJ), who will schedule and hold an evidentiary hearing. The ALJ will make an initial determination as to whether there is a violation of section 337; that initial determination is subject to review by the Commission.
The USITC will make a final determination in the investigation at the earliest practicable time. Within 45 days after institution of the investigation, the USITC will set a target date for completing the investigation. USITC remedial orders in section 337 cases are effective when issued and become final 60 days after issuance unless disapproved for policy reasons by the U.S. Trade Representative within that 60-day period.